Synthesis, anti-HIV activity and stability studies of 3′-azido-2′,3′-dideoxythymidine 5′-fluorophosphate

被引：4

作者：

Egron, D

Arzumanov, AA

Dyatkina, NB

Krayevsky, A

Imbach, JL

Aubertin, AM

Gosselin, G

Périgaud, C

机构：

[1] Univ Montpellier 2, Lab Chim Biorgan, UMR CNRS USTL 5625, F-34095 Montpellier 5, France

[2] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 117984, Russia

[3] Univ Strasbourg 1, Inst Virol, INSERM U74, F-67000 Strasbourg, France

来源：

NUCLEOSIDES & NUCLEOTIDES | 1999年 / 18卷 / 4-5期

关键词：

D O I：

10.1080/15257779908041621

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The synthesis, in vitro anti-HIV activity, and stability studies of AZT 5'-fluorophosphate (F-AZTMP) are reported. The present results demonstrate that such compound is a bioprecursor of its parent 5'-mononucleotide (AZTMP) but its biotransformation does not allow its selective intracellular delivery. Moreover, several attempts were carried out in order to improve the biological activity of this compound by the use of a SATE prodrug strategy.

引用

页码：983 / 984

页数：2

共 50 条

[21] Molecular Modelling Analyses of the Substituted 3′-Azido-2′,3′Dideoxythymidine
Ai-Fifi, Zarrag
Eid, May
Saleh, Noha A.
Ibrahim, Medhat
JOURNAL OF COMPUTATIONAL AND THEORETICAL NANOSCIENCE, 2014, 11 (02) : 409 - 412
[22] THE 5'-HYDROGEN PHOSPHONATE ANALOG AS A POTENTIAL PRODRUG OF 3'-AZIDO-2',3'-DIDEOXYTHYMIDINE (AZT)
BOAL, JH
IYER, RP
EGAN, W
NUCLEOSIDES & NUCLEOTIDES, 1993, 12 (10): : 1075 - 1084
[23] EFFECT OF 3'-AZIDO-2',3'-DIDEOXYTHYMIDINE ON EXPERIMENTAL VIRAL-INFECTIONS
SHNEIDER, MA
RUDENKO, NK
KAVSAN, VM
BIBILASHVILI, RS
KRAEVSKII, AA
KUKHANOVA, MK
MOLECULAR BIOLOGY, 1987, 21 (03) : 706 - 713
[24] 2'-AZIDO-2',3'-DIDEOXYTHYMIDINE - SYNTHESIS AND CRYSTAL-STRUCTURE OF A 2'-SUBSTITUTED DIDEOXYNUCLEOSIDE
VANAERSCHOT, A
EVERAERT, D
GOSSELIN, G
PEETERS, O
BLATON, N
DERANTER, C
IMBACH, JL
BALZARINI, J
DECLERCQ, E
HERDEWIJN, P
ANTIVIRAL RESEARCH, 1990, 14 (06) : 357 - 369
[25] The mechanism of 3′-azido-2′,3′-dideoxythymidine resistance to human lymphoid cells
Hoever, G
Groeschel, B
Chandra, P
Doerr, HW
Cinatl, J
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2003, 11 (06) : 743 - 747
[26] 3′-Azido-2′,3′-dideoxythymidine (zidovudine) uptake mechanisms in T lymphocytes
Purcet, Sergi
Minuesa, Gerard
Molina-Arcas, Miriam
Erkizia, Itziar
Casado, F. Javier
Clotet, Bonaventura
Martinez-Picado, Javier
Pastor-Anglada, Marcal
ANTIVIRAL THERAPY, 2006, 11 (06) : 803 - 811
[27] Irreversible telomere shortening by 3′-azido-2′,3′-dideoxythymidine (AZT) treatment
Gomez, DE
Tejera, AM
Olivero, OA
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 246 (01) : 107 - 110
[28] BRAIN TARGETING OF ANTI-HIV NUCLEOSIDES - ETHER PRODRUGS OF 3'-AZIDO-2',3'-DIDEOXYURIDINE (AZDU) AND 3'-AZIDO-3'-DEOXYTHYMIDINE (AZT)
DOSHI, KJ
ISLAM, Q
GALLO, JM
BOUDINOT, FD
HSIEH, L
QIN, Y
SCHINAZI, RF
CHU, CK
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1993, 4 (05): : 263 - 269
[29] Pharmacokinetics and tissue distribution of (±)-3′-azido-2′,3′-dideoxy-5′-O-(2-bromomyristoyl)thymidine a prodrug of 3′-azido-2′,3′-dideoxythymidine (AZT) in mice
Parang, K
Wiebe, LI
Knaus, EE
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (09) : 989 - 996
[30] SYNTHESIS, AND SOME PROPERTIES OF, AMPHIPHILIC DINUCLEOSIDE PHOSPHATE DERIVATIVES OF 3'-AZIDO-2',3'-DIDEOXYTHYMIDINE (AZT)
SCHOTT, H
HAUSSLER, MP
GOWLAND, P
HORBER, DH
SCHWENDENER, RA
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1994, 5 (06): : 387 - 394

← 1 2 3 4 5 →